Tirzepatide is a novel, dual-acting peptide that targets specific receptors to support metabolic regulation. Engineered for precision, it binds selectively to both GIP and GLP-1 receptors, optimizing its effectiveness in relevant applications. Known for its extended duration and targeted action, tirzepatide is developed for consistency and reliability in advanced research settings.
